Search Results - "Clarke, Jeffrey Melson" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Targeted inhibition of VEGF receptor 2: an update on ramucirumab

Targeted inhibition of VEGF receptor 2: an update on ramucirumab

by Clarke, Jeffrey Melson, Hurwitz, Herbert I
Published in Expert opinion on biological therapy (01.08.2013)

Get more information

Journal Article

$A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)$

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

by Clarke, Jeffrey Melson, Blobe, Gerard C., Strickler, John H., Uronis, Hope Elizabeth, Zafar, S. Yousuf, Morse, Michael, Dropkin, Evan, Howard, Leigh, O’Neill, Margot, Rushing, Christel N., Niedzwiecki, Donna, Watson, Hollie, Bolch, Emily, Arrowood, Christy, Liu, Yingmiao, Nixon, Andrew B., Hurwitz, Herbert I.
Published in Cancer chemotherapy and pharmacology (01.10.2019)

Get full text

Journal Article

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients

by Le, Xiuning, Goldman, Jonathan Wade, Clarke, Jeffrey Melson, Tchekmedyian, Nishan, Piotrowska, Zofia, Chu, David, Bhat, Gajanan, Lebel, Francois M., Socinski, Mark A.
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

The relationship between patient-reported distress and healthcare utilization in mNSCLC

The relationship between patient-reported distress and healthcare utilization in mNSCLC

by Bodd, Monica Himaani, Locke, Susan C., Herring, Kris W., Troy, Jesse D, Wolf, Steven, Clarke, Jeffrey Melson, LeBlanc, Thomas William
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

ctDNA detection in patients with brain metastases arising from solid tumors

ctDNA detection in patients with brain metastases arising from solid tumors

by Alder, Laura, Broadwater, Gloria, Green, Michelle, Lipp, Eric S., Van Swearingen, Amanda E.D., Clarke, Jeffrey Melson, Anders, Carey K., Sammons, Sarah
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

Sotorasib plus carboplatin and pemetrexed in KRAS G12C advanced NSCLC: Updated analysis from the international CodeBreaK 101 trial

Sotorasib plus carboplatin and pemetrexed in KRAS G12C advanced NSCLC: Updated analysis from the international CodeBreaK 101 trial

by Li, Bob T., Clarke, Jeffrey Melson, Felip, Enriqueta, Ruffinelli, Jose Carlos, Garrido, Pilar, Zugazagoitia, Jon, Goldberg, Sarah B., Ramalingam, Suresh S., Victoria, Iván, Puri, Sonam, Gandara, David R., Kormany, William, Edmonds, Sophie, Palmer, Kerry, Gupta, Ravi G., Govindan, Ramaswamy
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

Results from a first-in-human phase 1B study of a complement factor H inhibitor (GT103) in patients with non-small cell lung cancer (NSCLC)

Results from a first-in-human phase 1B study of a complement factor H inhibitor (GT103) in patients with non-small cell lung cancer (NSCLC)

by Clarke, Jeffrey Melson, Stinchcombe, Tom, Gu, Lin, Mamdani, Hirva, Antonia, Scott Joseph, Simon, George R., Sonpavde, Guru P., Ready, Neal E., Crawford, Jeffrey, Campa, Michael, Gottlin, Elizabeth, Bushey, Ryan, Herndon, James Emmett, Patz, Edward
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

CNS activity of poziotinib in NSCLC with exon 20 insertion mutations

CNS activity of poziotinib in NSCLC with exon 20 insertion mutations

by Le, Xiuning, Garassino, Marina Chiara, Cornelissen, Robin, Socinski, Mark A., Tchekmedyian, Nishan, Molina, Julian R., Baik, Christina S, Leu, Sharon, Dreiling, Lyndah, Lebel, Francois M., Clarke, Jeffrey Melson
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Novel cancer therapies and their association with diabetes

Novel cancer therapies and their association with diabetes

by Shariff, Afreen Idris, Syed, Sohail, Shelby, Rebecca A, Force, Jeremy, Clarke, Jeffrey Melson, D’Alessio, David, Corsino, Leonor
Published in Journal of molecular endocrinology (01.02.2019)

Get full text

Journal Article

Interim results from the OPTIMAL trial: A phase II clinical trial of combination nivolumab, ipilimumab, and taxane in patients with untreated metastatic non-small cell lung cancer (NSCLC)

Interim results from the OPTIMAL trial: A phase II clinical trial of combination nivolumab, ipilimumab, and taxane in patients with untreated metastatic non-small cell lung cancer (NSCLC)

by Clarke, Jeffrey Melson, Wang, Xiaofei F., Gu, Lin, Stevenson, Marvaretta Miesha, Stinchcombe, Tom, Ramalingam, Sundhar, Antonia, Scott Joseph, Shariff, Afreen, Garst, Jennifer, Crawford, Jeffrey, Ready, Neal E.
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

Preliminary clinical outcomes of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced urothelial cancer

Preliminary clinical outcomes of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced urothelial cancer

by Aggen, David H, Hong, David S., Clarke, Jeffrey Melson, Asch, Adam Steven, Calvo, Emiliano, Zugazagoitia, Jon, Butler, Marcus O., Moreno, Victor, Cervantes, Andres, Van Tine, Brian Andrew, Lawrence, Donald P., Johnson, Melissa Lynne, Brophy, Francine Elizabeth, Broad, Robyn, Isabelle, Martin, Gunn, Alasdair, Navenot, Jean-Marc, Saro, Jose, Norry, Elliot, Charlson, John A.
Published in Journal of clinical oncology (20.02.2023)

Get full text

Journal Article

Safety and efficacy from the phase 1 SURPASS trial of ADP-A2M4CD8, a next-generation T-cell receptor T-cell therapy, in patients with advanced esophageal, esophagogastric junction, or gastric cancer

Safety and efficacy from the phase 1 SURPASS trial of ADP-A2M4CD8, a next-generation T-cell receptor T-cell therapy, in patients with advanced esophageal, esophagogastric junction, or gastric cancer

by Blum Murphy, Mariela A., Ajani, Jaffer A., Van Tine, Brian Andrew, Clarke, Jeffrey Melson, Butler, Marcus O., Lawrence, Donald P., Johnson, Melissa Lynne, Cervantes, Andres, Moreno, Victor, Hong, David S., Brophy, Francine Elizabeth, Navenot, Jean-Marc, Lin, Quan, Saro, Jose, Norry, Elliot
Published in Journal of clinical oncology (01.02.2023)

Get full text

Journal Article

Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors

Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors

by Kao, Chester, Powers, Eric, Datto, Michael B., Green, Michelle, Harrison, Michael Roger, Armstrong, Andrew J., George, Daniel J., Clarke, Jeffrey Melson, Strickler, John H., Zhang, Tian
Published in Journal of clinical oncology (10.02.2020)

Get full text

Journal Article

RNA turbulence by tumor type: Overexpression of actionable mRNA signaling pathways by histology

RNA turbulence by tumor type: Overexpression of actionable mRNA signaling pathways by histology

by Patel, Sandip Pravin, Morris, Scott, Chae, Young Kwang, Clarke, Jeffrey Melson
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study

Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: A single institution, retrospective cohort study

by Tan, Irena, Stinchcombe, Tom, Ready, Neal E., Datto, Michael B., Nagy, Rebecca J, Gu, Lin, Clarke, Jeffrey Melson
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Real-world (rw) clinical outcomes for advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) treated with second line (2L) ramucirumab plus docetaxel (R+D) post frontline (1L) platinum based chemotherapy plus immune checkpoint inhibitors (Pt + ICI)

Real-world (rw) clinical outcomes for advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) treated with second line (2L) ramucirumab plus docetaxel (R+D) post frontline (1L) platinum based chemotherapy plus immune checkpoint inhibitors (Pt + ICI)

by Clarke, Jeffrey Melson, Mathur, Raina, Molife, Cliff, Batus, Marta, Stefaniak, Victoria Jennifer, Winfree, Katherine B., Baxi, Shrujal, Cui, Zhanglin Lin, Lenis, David, Bonomi, Philip D.
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Real-world tumor response (rwTR) to ramucirumab plus docetaxel (R+D) post platinum-based (Pt) and immune checkpoint inhibitor (ICI) therapy in advanced non-small cell lung cancer (aNSCLC) patients (pts)

Real-world tumor response (rwTR) to ramucirumab plus docetaxel (R+D) post platinum-based (Pt) and immune checkpoint inhibitor (ICI) therapy in advanced non-small cell lung cancer (aNSCLC) patients (pts)

by Clarke, Jeffrey Melson, Mathur, Raina, Molife, Cliff, Batus, Marta, Stefaniak, Victoria Jennifer, Winfree, Katherine B., Baxi, Shrujal, Cui, Zhanglin Lin, Lenis, David, Bonomi, Philip D.
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Real-world clinical burden of aggressive disease (AD) in advanced/metastatic non small cell lung cancer (aNSCLC)

Real-world clinical burden of aggressive disease (AD) in advanced/metastatic non small cell lung cancer (aNSCLC)

by Batus, Marta, Stefaniak, Victoria Jennifer, Molife, Cliff, Clarke, Jeffrey Melson, Winfree, Katherine B., Mitchell, Lucy, Cui, Zhanglin Lin, Bonomi, Philip D.
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Real-world characterization of advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) with rapid disease progression (RDP)

Real-world characterization of advanced/metastatic non-small cell lung cancer (aNSCLC) patients (pts) with rapid disease progression (RDP)

by Gutierrez, Martin, Molife, Cliff, Belli, Andrew J., Hansen, Eric, Stefaniak, Victoria Jennifer, Winfree, Katherine B., Cui, Zhanglin Lin, Batus, Marta, Clarke, Jeffrey Melson, Narayanan, Viraj, Manion, Chelsea, Norden, Andrew David, Bonomi, Philip D.
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Veliparib in combination with nivolumab and platinum doublet chemotherapy (CT) in metastatic/advanced NSCLC

Veliparib in combination with nivolumab and platinum doublet chemotherapy (CT) in metastatic/advanced NSCLC

by Clarke, Jeffrey Melson, Patel, Jyoti D., Robert, Francisco, Kio, Ebenezer A., Thara, Eddie, Garofalo, Brage, Barnes, Marcia, Tian, Tian, Qin, Qin Q., Dunbar, Martin, Nuthalapati, Silpa, Selvaggi, Giovanni, McKee, Mark D., Dinh, Minh, Camidge, D. Ross
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article